Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

World Cancer Day Focuses on Cancer-Infection Link

February 9, 2010
Publication
Article
OncologyONCOLOGY Vol 24 No 2
Volume 24
Issue 2

In the lead up to World Cancer Day on February 4, the theme of a campaign launched by the International Union Against Cancer (UICC) was “Cancer can be prevented too.” The campaign was backed by a new scientific report, “Protection Against Cancer-Causing Infections,” which focuses on the nine infections that can lead to cancer.

In the lead up to World Cancer Day on February 4, the theme of a campaign launched by the International Union Against Cancer (UICC) was “Cancer can be prevented too.” The campaign was backed by a new scientific report, “Protection Against Cancer-Causing Infections,” which focuses on the nine infections that can lead to cancer.

“Of the 12 million people who are diagnosed with cancer each year, around 20% of cases can be attributed to viral and bacterial infections that either directly cause or increase the risk of cancer,” said Prof. David Hill, UICC President. “For this reason the UICC, with over 300 member organizations in more than 100 countries, has focused this year’s World Cancer Day campaign on increasing awareness of the contribution of infections to the global cancer burden.”

Despite the existence of preventive measures (the HPV vaccine, which protects against the human papillomavirus that can lead to cervical cancer, and the vaccine against hepatitis B virus, which can lead to liver cancer), there is a clear disparity between low- and high-income countries in incidence rates of cancer related to infections (26% vs 8%), as well as access to prevention programs, treatment, and care. For example, 80% of global cervical cancer deaths are in developing countries, and even where affordable technology is available, enormous challenges remain due to limitations in disease awareness and public health infrastructures.

Articles in this issue

ONCOLOGY Continuing Medical Education February 2010
HDAC Inhibitors in Cancer Care
‘Vitamin R’ and Its Younger Siblings
Clarifying the Role of Neoadjuvant Therapy in Breast Cancer
A Multidisciplinary Approach to Neoadjuvant Therapy for Primary Operable Breast Cancer
HDAC Inhibitors: Much to Learn About Effective Therapy
HDAC Inhibitor Research: Still in Its Infancy
Monoclonal Antibodies in Advanced B-cell Lymphomas
Fighting a Smarter War on Cancer
Costs Play Role in Oncologists’ Treatment Recommendations, But Most Physicians Do Not Discuss Cost Issues With Patients
Proteomics Study Reveals a Protein Tied to Taxane Resistance
Improving Our Use and Understanding of Antibodies in B-cell Lymphomas
Gerson Regimen
Gerson Regimen
FDA Approves Addition of Sustained Overall Survival Benefit to Label for Bortezomib
World Cancer Day Focuses on Cancer-Infection Link

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
Related Content

7 Metaplastic Breast Cancer: A Retrospective Chart Review of Clinical Features

7 Metaplastic Breast Cancer: A Retrospective Chart Review of Clinical Features

Nidhi Navaratna;Mariam Aoun;Nitya Batra;Mohammad Muhsin Chisti, MD
July 11th 2025
Article


Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD
March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.


9 Body Mass Index, Cancer Risk Behaviors, and Readiness for Dietary Change Among Women Surviving With Breast Cancer

9 Body Mass Index, Cancer Risk Behaviors, and Readiness for Dietary Change Among Women Surviving With Breast Cancer

Marcelo Sleiman Jr;Muriel Statman;Anthony Zisa;Duye Liu;Adina Fleischmann;Kenneth Tercyak
July 9th 2025
Article

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD
March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.


12 Gut Microbiome Composition and Pathological Complete Response After Chemotherapy in Breast Cancer: Insights From a Pilot Study

12 Gut Microbiome Composition and Pathological Complete Response After Chemotherapy in Breast Cancer: Insights From a Pilot Study

Diana Kantarovich;Olutayo Sogunro;Christopher Umbricht;Catherine E. Klein, MD;James White;Mehran Habibi
July 7th 2025
Article

As AI revolutionizes cancer care by enhancing diagnosis, treatment, and clinical trial matching, it may lead to improved patient outcomes and streamlined workflows.

Current Use and Future Directions of Artificial Intelligence in Hematology/Oncology

Julie M. Vose, MD, MBA
July 5th 2025
Article

As AI revolutionizes cancer care by enhancing diagnosis, treatment, and clinical trial matching, it may lead to improved patient outcomes and streamlined workflows.

Related Content

7 Metaplastic Breast Cancer: A Retrospective Chart Review of Clinical Features

7 Metaplastic Breast Cancer: A Retrospective Chart Review of Clinical Features

Nidhi Navaratna;Mariam Aoun;Nitya Batra;Mohammad Muhsin Chisti, MD
July 11th 2025
Article


Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD
March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.


9 Body Mass Index, Cancer Risk Behaviors, and Readiness for Dietary Change Among Women Surviving With Breast Cancer

9 Body Mass Index, Cancer Risk Behaviors, and Readiness for Dietary Change Among Women Surviving With Breast Cancer

Marcelo Sleiman Jr;Muriel Statman;Anthony Zisa;Duye Liu;Adina Fleischmann;Kenneth Tercyak
July 9th 2025
Article

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD
March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.


12 Gut Microbiome Composition and Pathological Complete Response After Chemotherapy in Breast Cancer: Insights From a Pilot Study

12 Gut Microbiome Composition and Pathological Complete Response After Chemotherapy in Breast Cancer: Insights From a Pilot Study

Diana Kantarovich;Olutayo Sogunro;Christopher Umbricht;Catherine E. Klein, MD;James White;Mehran Habibi
July 7th 2025
Article

As AI revolutionizes cancer care by enhancing diagnosis, treatment, and clinical trial matching, it may lead to improved patient outcomes and streamlined workflows.

Current Use and Future Directions of Artificial Intelligence in Hematology/Oncology

Julie M. Vose, MD, MBA
July 5th 2025
Article

As AI revolutionizes cancer care by enhancing diagnosis, treatment, and clinical trial matching, it may lead to improved patient outcomes and streamlined workflows.

Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.